These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2319928)

  • 21. The NMR blood test for cancer: current status.
    Fossel ET
    Cancer Cells; 1991 May; 3(5):173-82. PubMed ID: 1654067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR in cancer. X. A malignancy index to discriminate normal and cancerous tissue.
    Koutcher JA; Goldsmith M; Damadian R
    Cancer; 1978 Jan; 41(1):174-82. PubMed ID: 626927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: methodological aspects and clinical relevance.
    Engan T
    Anticancer Res; 1996; 16(3B):1461-71. PubMed ID: 8694514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
    Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
    Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: significant variations with extent of breast cancer, duration of pregnancy and aging.
    Engan T; Krane J; Kvinnsland S
    NMR Biomed; 1991 Jun; 4(3):142-9. PubMed ID: 1911102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear magnetic resonance in cancer, XII: Application of NMR malignancy index to human lung tumours.
    Goldsmith M; Koutcher JA; Damadian R
    Br J Cancer; 1977 Aug; 36(2):235-42. PubMed ID: 911662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic phenotyping of human plasma by
    Louis E; Cantrelle FX; Mesotten L; Reekmans G; Bervoets L; Vanhove K; Thomeer M; Lippens G; Adriaensens P
    Magn Reson Chem; 2017 Aug; 55(8):706-713. PubMed ID: 28061019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of human tumors from nonmalignant tissue by natural-abundance 13C NMR spectroscopy.
    Halliday KR; Fenoglio-Preiser C; Sillerud LO
    Magn Reson Med; 1988 Aug; 7(4):384-411. PubMed ID: 2459580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 750 MHz 1H-NMR spectroscopy of human blood plasma.
    Foxall PJ; Spraul M; Farrant RD; Lindon LC; Neild GH; Nicholson JK
    J Pharm Biomed Anal; 1993; 11(4-5):267-76. PubMed ID: 8357863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution diffusion and relaxation edited one- and two-dimensional 1H NMR spectroscopy of biological fluids.
    Liu M; Nicholson JK; Lindon JC
    Anal Chem; 1996 Oct; 68(19):3370-6. PubMed ID: 8843135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [1H-NMR studies of plasma from patients with liver diseases].
    Ono S; Moriyasu F; Tamada T; Kawasaki T; Yamashita Y; Kimura T; Kajimura K; Someda H; Hamato N; Okuma M
    Nihon Shokakibyo Gakkai Zasshi; 1990 Dec; 87(12):2623-8. PubMed ID: 2077159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
    Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
    J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostatic tumors. Detection by proton nuclear magnetic resonance spectroscopy of plasma lipoproteins].
    Nabholtz JM; Tremeaux JC; Rossignol A; Farnier M; Gambert P; Briet S; Guerrin J
    J Urol (Paris); 1989; 95(4):209-12. PubMed ID: 2477463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staging research of human lung cancer tissues by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy (HRMAS
    Chen W; Lu S; Wang G; Chen F; Bai C
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e232-e238. PubMed ID: 27670847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proton NMR of blood plasma and the test for cancer.
    Herring FG; Phillips PS; Pritchard H; Silver H; Whittal KP
    Magn Reson Med; 1990 Oct; 16(1):35-48. PubMed ID: 2175009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid domain in cancer cell plasma membrane shown by 1H NMR to be similar to a lipoprotein.
    Williams PG; Helmer MA; Wright LC; Dyne M; Fox RM; Holmes KT; May GL; Mountford CE
    FEBS Lett; 1985 Nov; 192(1):159-64. PubMed ID: 4054314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
    Pasanen PA; Kauppinen R; Eskelinen M; Partanen K; Pikkarainen P; Alhava E
    Anticancer Res; 1993; 13(3):763-8. PubMed ID: 8317910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The contribution of discrimination analysis to the diagnostic decision in patients with lung carcinoma.
    Procházka J; Stulíková V; Sobĕslavský C; Deyl Z; Eliás M; Helbich P
    Neoplasma; 1989; 36(3):333-41. PubMed ID: 2739812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMR spectroscopy evaluation of plasma "oncolipids" in head and neck cancer.
    Scher RL; Ropka ME; Neal DA; Berr S; Trouard T; Deutsch B; Cantrell RW; Levine PA
    Otolaryngol Head Neck Surg; 1990 Jan; 102(1):34-40. PubMed ID: 2106116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [NMR research on blood plasma for tumor detection--a method for mass screening?].
    Fritzsche H; Sprinz H; Jahn H; Jorke D
    Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.